Aurora Cannabis Subsidiary Safari Flower Company Secures EU-GMP Certification

Safari Flower Company, a wholly owned subsidiary of Aurora Cannabis Inc., has obtained European Union Good Manufacturing Practice (EU-GMP) certification for its facility in Ontario, Canada. This three-year certification validates the company's adherence to high international standards for quality and compliance, enabling it to serve global medical cannabis markets.

The certification marks a significant milestone for Safari Flower Company, reinforcing its capabilities in producing and manufacturing medical cannabis for regulated international markets. Brigitte Simons, CEO of Safari Flower Company, stated that the achievement solidifies the company's position as a trusted provider of high-quality medical cannabis and reflects a strong culture of compliance and operational excellence.

Located in Ontario's Niagara Region, the 59,000-square-foot facility has a history of EU-GMP accreditations and export operations. Aurora Cannabis acquired Safari Flower Company in April 2026 to augment its global manufacturing capacity and support the supply of medical cannabis to key international markets, including Germany, Poland, and the UK.

As international medical cannabis markets continue to evolve, EU-GMP certification is essential for Safari Flower Company to confidently supply regulated markets. The company aims to meet rigorous quality, safety, and compliance standards, addressing the growing patient demand worldwide.